PT-141 Chemistry: Cyclic Melanocortin Peptide
A bench-level reference sheet on bremelanotide, the cyclic melanocortin peptide: where it sits in the melanocortin family, how the ring is assembled, and what to read off the sequence before keeping one as a reference standard.
Sequence and Structure
PT-141, known chemically as bremelanotide, is a small cyclic peptide built on seven residues. Unlike the longer linear peptides in the catalog, its defining structural feature is the ring: the chain is closed on itself, which locks the backbone into a more rigid, conformationally defined shape. That constraint is the whole point of the molecule, since a fixed ring presents its key side chains in a consistent geometry rather than letting an open chain sample many shapes.
The sequence is a metabolite of the earlier alpha-MSH analog family and retains the conserved core motif that the melanocortin class is built around. For a research chemist the practical takeaway is that the cyclization is the load-bearing structural decision: it changes how the peptide elutes, how it resists enzymatic trimming, and how cleanly it can be made. Reading the cyclic architecture off the structure before ordering tells you most of what you need to know about how the material will behave on the column and in the freezer.
The Melanocortin Family
PT-141 belongs to the melanocortin family, a group of peptides derived from the proopiomelanocortin precursor and centered on the alpha-MSH sequence. Members of this family share a conserved His-Phe-Arg-Trp core, the motif that defines recognition at the melanocortin receptors, and they are studied as agonists across that receptor set. Understanding that shared core is useful because it explains why melanocortin compounds tend to respond to similar synthetic and analytical methods.
Within the family, the research catalog spans linear alpha-MSH analogs and the cyclic constructs that constrain the core into a fixed ring. Melanotan II is the close cyclic relative most chemists reach for as a comparison point, since it shares the lactam-cyclization strategy and the same conserved core. Treating PT-141 as one node in that family, rather than as an isolated molecule, makes it easier to anticipate how it will behave under synthesis, analysis, and storage.
Synthesis and Cyclization
PT-141 is assembled by Fmoc solid-phase peptide synthesis, the same base-labile strategy used across the reference catalog. At seven residues the linear precursor is short and assembles quickly, but the work that defines the molecule comes after the chain is built: the peptide is cyclized to close the ring. Cyclization is typically achieved through a side-chain to side-chain bridge between selectively protected residues, formed either on resin or in dilute solution after cleavage to favor the intramolecular reaction over chain-to-chain coupling.
That cyclization step is where most of the purity profile is decided. Incomplete ring closure leaves a linear contaminant, and aggressive conditions can produce dimers, so research-grade routes use orthogonal protection and controlled dilution to keep the reaction clean. The same logic governs the related cyclic melanocortins, which is why the characterization below leans hard on separating the cyclic product from its linear and oligomeric relatives.
Characterization
Identity and purity for a cyclic melanocortin peptide are established with the same two complementary tools used across the reference catalog. Reversed-phase HPLC reports the purity figure, the percentage of the total peak area attributable to the target peptide, and it separates the closed cyclic product from the linear precursor and any partially cyclized or dimeric species that can accompany it. Mass spectrometry confirms identity by matching the measured mass to the expected mass for the cyclic sequence, where the ring closure shows up as the loss of a small, predictable mass relative to the linear form.
Reading these together matters. An HPLC purity number describes how much of the sample is the intended cyclic peptide relative to other UV-absorbing species, while the mass result confirms that the main peak is in fact the cyclized molecule rather than its open-chain relative of similar size. Both pieces of information describe the chemistry of a given sequence, and a research chemist should expect to interpret them together rather than in isolation.
Stability and Storage
As lyophilized powder, cyclic melanocortin peptides are comparatively stable when kept cold, dry, and out of light. Long-term storage of the dry solid is typically at freezer temperatures, with the container protected from moisture so the hygroscopic powder does not pick up water on opening. Allowing a sealed vial to reach room temperature before it is opened helps avoid condensation on the cold contents. The ring confers some resistance to exopeptidase trimming, but it does not exempt the peptide from ordinary chemical degradation.
Once reconstituted, the working solution is far less forgiving. Peptides in solution are subject to hydrolysis, oxidation, and adsorption to surfaces, so reconstituted material is generally held cold and used within a short window, with freeze-thaw cycles minimized. These are general handling principles for research peptides rather than claims about any one preparation, and the documentation for a given standard should be the reference of record for its own conditions.
What PT-141 Is Studied For (Chemistry Only)
In a research-chemistry context, PT-141 is of interest as a tractable model system for melanocortin structure-activity work. As a constrained cyclic analog of a linear parent, it lets chemists study how ring closure changes a peptide's stability, solubility, and chromatographic behavior, and how a fixed conformation alters recognition at the melanocortin receptors relative to the flexible chain. It also serves as a well characterized reference point when validating synthesis and analytical methods on related melanocortin compounds.
That framing is deliberately limited to the bench. These materials are reference standards for laboratory research only, and nothing here describes or implies any human or veterinary use or outcome. The value of PT-141 to a research chemist is as a chemistry subject, a cyclic melanocortin whose behavior under synthesis, analysis, and storage is well understood and worth knowing in detail.
This overview is provided for laboratory and research use only. It is educational chemistry reference material and is not for human or veterinary consumption. Buyers are responsible for compliance with all applicable laws and regulations.
What is PT-141 and what family does it belong to?
PT-141, also called bremelanotide, is a cyclic seven-residue peptide in the melanocortin family. It is a synthetic analog related to alpha-MSH and is studied as a melanocortin-receptor agonist. In a catalog it sits alongside other melanocortin compounds such as Melanotan II, and it is supplied strictly as a research reference standard.
How is PT-141 synthesized and made cyclic?
PT-141 is assembled by Fmoc solid-phase peptide synthesis as a linear precursor, then closed into its cyclic form. Cyclization improves conformational definition and resistance to exopeptidases. The ring is typically formed through a side-chain to side-chain bridge between suitably protected residues, which is the step that most shapes the final purity profile.
How is the identity and purity of PT-141 confirmed?
Identity and purity are established with two complementary methods. Reversed-phase HPLC reports purity as the percentage of total peak area attributable to the target peptide and separates it from related linear or partially cyclized species. Mass spectrometry confirms identity by matching the measured mass to the expected mass for the cyclic sequence. The two are read together.
How should PT-141 be stored?
As a lyophilized powder, PT-141 is comparatively stable when kept cold, dry, and out of light, with long-term storage of the dry solid typically at freezer temperatures. Letting a sealed vial reach room temperature before opening helps avoid condensation. Once reconstituted, the solution is far less forgiving and is generally held cold, used within a short window, and protected from repeated freeze-thaw.